Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (The MONICA project-Toulouse)

This publication has 14 references indexed in Scilit:

• Use of Medical Resources and Quality of Life after Acute Myocardial Infarction in Canada and the United States
  New England Journal of Medicine, 1994
• Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial
  Journal of the American College of Cardiology, 1993
• Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial
  Journal of the American College of Cardiology, 1992
• Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?
  New England Journal of Medicine, 1992
• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990
• Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction
  American Heart Journal, 1990
• Comparison of cardiovascular risk factor levels in two French populations: Haute‐Garonne (Toulouse) and Bas‐Rhin (Strasbourg)
  Acta Medica Scandinavica, 1988
• Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction
  New England Journal of Medicine, 1986
• Left ventricular function after myocardial infarction: Clinical and angiographic correlations
  Journal of the American College of Cardiology, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985